Synonyms: ABT-555 | AE12-1Y-QL
Compound class:
Antibody
Comment: Elezanumab (ABT-555) is a fully human monoclonal antibody targeting repulsive guidance molecule-a (RGMA), in development as a potential therapy for multiple sclerosis (MS).
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. BLAST peptide anaylsis reveals identical matches with peptides claimed in patent WO2013112922 [2]. |
Classification ![]() |
|
Compound class | Antibody |
International Nonproprietary Names ![]() |
|
INN number | INN |
10344 | elezanumab |
Synonyms ![]() |
ABT-555 | AE12-1Y-QL |
Database Links ![]() |
|
Specialist databases | |
IMGT/mAb-DB | 650 |
Other databases | |
GtoPdb PubChem SID | 318164809 |
Search PubMed clinical trials | elezanumab |
Search PubMed titles | elezanumab |
Search PubMed titles/abstracts | elezanumab |